Canada Spends Logo

Explore our Budget 2026 analysis

Program directory · Public Health Agency of Canada

Communicable Disease and Infection Control

Program code
BVQ02 (PHAC)
Core responsibility
Infectious Disease Prevention and Control
In Departmental Plans
2018-19 – 2026-27 · New since an earlier plan

What it does

This Program’s objective is to protect Canadians from the spread of infectious disease in communities and healthcare settings. By achieving its objectives this Program provides national leadership on health promotion and infectious disease prevention. The Program collaborates with domestic and international stakeholders to share knowledge, tools, and resources to support public health front-line efforts, including targeted community-based interventions, to prevent, control, and reduce community and healthcare associated infections.

Source: the department's Program Inventory, via GC InfoBase.

History and lineage

First appears in GC InfoBase's actual spending by program in 2018-19. The data does not record when a program was created; it may be older than its first appearance here, which is limited by the sources (program spending starts in 2010-11, Departmental Plans in 2018-19).

2018-192019-202020-212021-222022-232023-242024-252025-262026-272027-282028-29Communicable Disease and Infection Control 2018-19: $65.8MCommunicable Disease and Infection Control 2019-20: $74MCommunicable Disease and Infection Control 2020-21: $281MCommunicable Disease and Infection Control 2021-22: $665MCommunicable Disease and Infection Control 2022-23: $1.59BCommunicable Disease and Infection Control 2023-24: $187MCommunicable Disease and Infection Control 2024-25: $129MCommunicable Disease and Infection Control 2025-26: $99.6MCommunicable Disease and Infection Control 2026-27: $101MCommunicable Disease and Infection Control 2027-28: $86.1MCommunicable Disease and Infection Control 2028-29: $84.6MCommunicable Disease and Infection Control
Bars: spending by fiscal year (dark: actual; light: actual restated on the 2017-18 program structure; outlined: the latest plan's forecast; grey: related programs). Bands: each program in the lineage over the years it has data.
ProgramRelationYears with dataActual spending over those years
Communicable Disease and Infection ControlThis program2018-19 – 2028-29$2.99B

No earlier or later program in the same department has a similar name.

Significant changes in scope and budget

Detected from the data: renames between plans, programs it appears to replace, merge with or split into (matched by name), year-over-year changes in spending of at least 25% and $5M, or in employees of at least 20% and 25 FTEs, linked budget measures, and results indicators added or dropped.

YearWhat changedSource
2020-21Spending $281M, against $74M in 2019-20 (+280%).Actual spending (GC InfoBase)
2021-22Employees (FTEs) 390, against 286 in 2020-21 (+36%).FTEs (GC InfoBase)
2021-22Spending $665M, against $281M in 2020-21 (+136%).Actual spending (GC InfoBase)
2022-23Employees (FTEs) 557, against 390 in 2021-22 (+43%).FTEs (GC InfoBase)
2022-23Spending $1.59B, against $665M in 2021-22 (+139%).Actual spending (GC InfoBase)
2023-24Spending $187M, against $1.59B in 2022-23 (−88%).Actual spending (GC InfoBase)
2024-25Spending $129M, against $187M in 2023-24 (−31%).Actual spending (GC InfoBase)
2025-26Planned employees (FTEs) 350, against 592 in 2024-25 (−41%).FTEs (GC InfoBase)
2026-27Indicators added: % of respondents from key populations who reported the adoption of evidence-based HIV, hepatitis C, or related Sexually Transmitted and Blood-Borne Infections (STBBI) prevention measures or harm reduction strategiesDepartmental Results Framework (GC InfoBase)
2026-27Indicators dropped: Rate of a key antimicrobial resistant infection identified among people in hospitals; Rate per 100,000 of new diagnosed cases of Human Immunodeficiency Virus (HIV)Departmental Results Framework (GC InfoBase)
2027-28Planned employees (FTEs) 285, against 404 in 2026-27 (−29%).FTEs (GC InfoBase)

Success criteria

The program's indicators from its department's Departmental Results Framework: the target set in each year's plan, and the result reported the following year. Source: GC InfoBase.

Historical: targets against results

Rate of a key antimicrobial resistant infection identified among people in hospitals
Expected result: Infectious diseases are prevented and controlled
22019-20– no result0.842022-23✗ not met

Bars: result reported. Dashed line: target.

Report yearTargetDueResultStatus
2019-20≤ 22020—
Data for this indicator will be available in late 2020, when shared data from partners is approved and available for distribution. There may be some delays in receiving partner data due to COVID-19 competing priorities.
No result reported
2022-23≤ 0.720250.84
0.84 Cases per 1,000 admissions (2021). Rate information is obtained from CNISP, which collects data related to healthcare-associated infections including antimicrobial resistant organisms from Canadian acute-care hospitals. There were no 2022–23 results available. The results from 2020 were the most recent available results in 2022–23 and will be used until new data for 2022–23 is made available.
Not met

Current: the 2026-27 plan's targets

No indicators in the 2026-27 plan.

Future goals: targets due after 2026-27

% of respondents from key populations who reported the adoption of evidence-based HIV, hepatitis C, or related Sexually Transmitted and Blood-Borne Infections (STBBI) prevention measures or harm reduction strategies
Expected result: Infectious diseases are prevented and controlled
70%2026-27

Bars: result reported. Dashed line: target.

Report yearTargetDueResultStatus
2026-27≥ 70%2028—Planned

Spending and employees: planned against actual

Spending

2018-19: $67.4M2018-19: $65.8M2018-192019-20: $70.4M2019-20: $74M2019-202020-21: $72.1M2020-21: $281M2020-212021-22: $231M2021-22: $665M2021-222022-23: $1.25B2022-23: $1.59B2022-232023-24: $96M2023-24: $187M2023-242024-25: $138M2024-25: $129M2024-252025-26: $99.6M2025-262026-27: $101M2026-272027-28: $86.1M2027-282028-29: $84.6M2028-29
Outlined bar: planned in that year's Departmental Plan (dashed: the latest plan, for years not yet reported). Filled bar: actual.
Show the numbers
Fiscal yearPlannedActual
2018-19$67.4M$65.8M
2019-20$70.4M$74M
2020-21$72.1M$281M
2021-22$231M$665M
2022-23$1.25B$1.59B
2023-24$96M$187M
2024-25$138M$129M
2025-26$99.6M—
2026-27$101M—
2027-28$86.1M*—
2028-29$84.6M*—

Employees (FTEs)

2018-19: 2482018-19: 2412018-192019-20: 2582019-20: 2822019-202020-21: 2842020-21: 2862020-212021-22: 5662021-22: 3902021-222022-23: 5922022-23: 5572022-232023-24: 3892023-24: 6612023-242024-25: 6102024-25: 5922024-252025-26: 3502025-262026-27: 4042026-272027-28: 2852027-282028-29: 2852028-29
Outlined bar: planned in that year's Departmental Plan (dashed: the latest plan, for years not yet reported). Filled bar: actual.
Show the numbers
Fiscal yearPlannedActual
2018-19248241
2019-20258282
2020-21284286
2021-22566390
2022-23592557
2023-24389661
2024-25610592
2025-26350—
2026-27404—
2027-28285*—
2028-29285*—

Planned spending, plan by plan

Each row is one year's Departmental Plan and its forecast for the next three fiscal years; read a column down to see how the forecast for one year changed. The last row is what was actually spent. Click an amount for its source. Biggest changes in federal spending plans

Actual spending is from Departmental Results Reports and the Public Accounts, as published in GC InfoBase. FTEs are full-time equivalents.